125 results
424B5
SCYX
Scynexis Inc
28 Nov 23
Prospectus supplement for primary offering
4:05pm
and other fungerps, such as SCY-247;
our expectations regarding the benefits we will obtain from the oral and IV form of ibrexafungerp and other … and other benefits under our license agreement with GSK;
our expectations regarding the marketing of ibrexafungerp and other fungerps, such as SCY-247
424B5
SCYX
Scynexis Inc
28 Nov 23
Prospectus supplement for primary offering
4:05pm
, such as SCY-247, including an IV formulation of ibrexafungerp and other fungerps, such as SCY-247;
our expectations regarding the benefits we will obtain … the timing and likelihood of achieving the milestone payments and other benefits under our license agreement with GSK;
our expectations regarding
S-8
EX-99.1
jfl gfhxot6i
18 Jul 23
Registration of securities for employees
4:28pm